Document Detail


Brain natriuretic peptide mediates the effect of creatinine clearance on development of left ventricular systolic dysfunction in patients with acute coronary syndrome.
MedLine Citation:
PMID:  20876054     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: There are only limited data about the role of renal function in the development of left ventricular systolic dysfunction in patients with an acute coronary syndrome (ACS). We sought to investigate whether renal insufficiency is an independent predictor for systolic dysfunction among patients who had an ACS.
METHODS: During 2006-2007, 814 consecutive patients who presented with an ACS event were enrolled prospectively; of these, 284 men (65 ± 14 years) and 71 women (71 ± 12 years) developed left ventricular systolic dysfunction (ejection fraction <40%), 306 men (64 ± 12 years) and 78 women (67 ± 10 years) had preserved left ventricular systolic function (ejection fraction >50%), while the rest of the patients (n=75), with ejection fraction between 40-50%, were excluded from this analysis. Creatinine clearance rates were estimated by the Cockcroft-Gault formula.
RESULTS: Eight percent of patients presented with severe and 30% with moderate renal dysfunction. Multiple logistic regression analysis revealed that a 10-unit increase of creatinine clearance levels decreases the odds of developing left ventricular systolic dysfunction by 8% (95%CI per 1 unit: 0.986-0.998), after controlling for potential confounders. Moreover, brain natriuretic peptide levels were inversely correlated with creatinine clearance (r=-0.378, p<0.001). When brain natriuretic peptide was entered into the model, creatinine clearance was not associated with left ventricular systolic dysfunction (OR=0.997, 95%CI 0.989-1.005).
CONCLUSIONS: The role of renal insufficiency in the development of left ventricular systolic dysfunction seems to be partially explained by plasma brain natriuretic peptide levels, suggesting a potential pathophysiological mechanism. Thus, patients with impaired creatinine levels and elevated brain natriuretic peptide levels should receive more aggressive medical care, as they are prone to developing left ventricular systolic dysfunction.
Authors:
Christina Chrysohoou; Christos Pitsavos; Panagiotis Aggelopoulos; George Metallinos; Eleftherios Tsiamis; Demosthenes Panagiotakos; Christodoulos Stefanadis
Related Documents :
9527094 - Comparison of atrial natriuretic peptide versus nitroglycerin for reducing blood pressu...
10562924 - Why is the concentration of plasma brain natriuretic peptide in elderly inpatients grea...
15912304 - The relation between endothelin-1 levels and myocardial injury in chronic ischemic hear...
10843904 - Et-1 in the myocardial interstitium: relation to myocyte ece activity and expression.
23217464 - Accessory mitral valve tissue: appearance on cardiac computed tomography.
15876804 - Are the high levels of cytomegalovirus antibodies a determinant in the development of c...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē     Volume:  51     ISSN:  2241-5955     ISO Abbreviation:  Hellenic J Cardiol     Publication Date:    2010 Sep-Oct
Date Detail:
Created Date:  2010-09-29     Completed Date:  2011-01-20     Revised Date:  2013-08-07    
Medline Journal Info:
Nlm Unique ID:  101257381     Medline TA:  Hellenic J Cardiol     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  413-20     Citation Subset:  IM    
Affiliation:
First Cardiology Department, University of Athens Medical School, Hippokration Hospital, Athens, Greece. chrysohoou@usa.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Coronary Syndrome / diagnosis,  physiopathology*
Aged
Creatine Kinase, MB Form / blood
Creatinine / metabolism*
Female
Heart Failure / diagnosis,  physiopathology
Humans
Logistic Models
Male
Middle Aged
Natriuretic Peptide, Brain / blood,  physiology*
Renal Insufficiency / physiopathology*
Retrospective Studies
Troponin I / blood
Ventricular Dysfunction, Left / metabolism,  physiopathology*
Chemical
Reg. No./Substance:
0/Troponin I; 114471-18-0/Natriuretic Peptide, Brain; 60-27-5/Creatinine; EC 2.7.3.2/Creatine Kinase, MB Form

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Slow-pathway ablation for atrioventricular nodal re-entrant tachycardia with no risk of atrioventric...
Next Document:  Aging and the cardiovascular system.